| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | https://www.hindustanbiosciences.in/ | |
| Market Cap | 8.91 Cr. | |
| Enterprise Value(EV) | 11.61 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 0.03 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | 318.14 | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 41.74 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 0.74 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 11.71 | Calculated using Price: 8.69 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 1.03 Cr. | 10,250,800 Shares |
| FaceValue | 2 | |
| About Hindustan Bio Sciences Ltd. | ||
| Hindustan Bio Sciences was incorporated in 1991. It is a limited company with a share capital of U.S $2.5 million based in Hyderabad, India. The people at the helm of affairs of the company are associated with pharmaceutical and healthcare sector for over two decades and are having penetrative knowledge of the needs of the sick. Hindustan Biosciences is a new entrant in the field of biopharmaceutical industry for providing quality healthcare for the treatment of life threatening diseases at affordable cost even to the lower income segment of Indian Society. | ||
| 1 Day |
|
-0.46% |
| 1 Week |
|
+6.79% |
| 1 Month |
|
+14.72% |
| 3 Month |
|
+1.05% |
| 6 Month |
|
-37.05% |
| 1 Year |
|
+62.59% |
| 2 Year |
|
+109.44% |
| 5 Year |
|
+820.21% |
| 10 Year |
|
+791.75% |
| 9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | -19.21 | -35.6 | -10.74 | -71.3 | 5.22 | 3.67 | -52.96 | -49.49 | -5.28 | |
| Return on Capital Employed (%) | -16.78 | -30.17 | -8.37 | -49.03 | 2.68 | 2.4 | -23.7 | -16.66 | -1.1 | |
| Return on Assets (%) | -16.51 | -30.15 | -8.42 | -47.82 | 2.37 | 1.45 | -20.83 | -16.05 | -1.29 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 7 | 5 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | |
| Non Curr. Liab. | 1 | 0 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | |
| Curr. Liab. | 0 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 8 | 6 | 6 | 4 | 6 | 6 | 3 | 3 | 3 | 3 | |
| Non Curr. Assets | 7 | 5 | 5 | 3 | 4 | 3 | 2 | 2 | 2 | 2 | |
| Curr. Assets | 1 | 1 | 1 | 0 | 2 | 2 | 1 | 1 | 1 | 1 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 8 | 6 | 6 | 4 | 6 | 6 | 3 | 3 | 3 | 3 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 1 | 1 | 1 | 1 | 4 | 2 | 1 | 0 | 1 | 1 | |
| Other Income | 0 | 0 | |||||||||
| Total Income | 1 | 1 | 1 | 1 | 4 | 2 | 1 | 0 | 1 | 1 | |
| Total Expenditure | -2 | -1 | -1 | -3 | -3 | -2 | -2 | -1 | -1 | -1 | |
| PBIDT | -1 | 0 | 0 | -2 | 0 | 0 | -1 | -1 | 0 | 0 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | |||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Taxation | 0 | 0 | 0 | ||||||||
| Exceptional Items | -2 | ||||||||||
| PAT | -1 | -2 | 0 | -2 | 0 | 0 | -1 | -1 | 0 | 0 | |
| Adjusted EPS | -1 | -2 | 0 | -2 | 0 | 0 | -1 | -1 | 0 | 0 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | 0 | 0 | 0 | 0 | -1 | 1 | 1 | 0 | 0 | |
| Cash Fr. Inv. | 0 | 0 | |||||||||
| Cash Fr. Finan. | 1 | 0 | -1 | 0 | 0 | 2 | -1 | -1 | 0 | 0 | |
| Net Change | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Thu, 18 Apr 2024
Reg. 40(10) PCS Certificate For The Year Ended 31-03-2024 Reg.40(10) PCS Certificate for the year ended 31-03-2024 |
|
Fri, 12 Apr 2024
Compliance Certificate U/R 7(3) For The Year Ended 31-03-2024 Compliance Certificate U/R 7(3) for the year ended 31-03-2024 |
|
Sat, 06 Apr 2024
Non-Applicability Of Criteria Of Large Corporate - Initial Disclosure Non-applicability of criteria of large corporate - initial disclosure |
| Thu, 25 Apr 2024 |
Opening at Low
|
High Increase in 1 Month
|
High Decrease in 6 Months
|
High Increase in 1 Year
|
High Increase in 2 Years
|
